Posters

Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome

Poster Details

First Author: T.Sarenac Vulovic SERBIA

Co Author(s):    D. Todorovic   S. Jovanovic   .               

Abstract Details

Purpose:

The purpose of the study was to quantify macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome.

Setting:

Patients were enrolled between January 2019 and Decembre 2019 as per the national guidelines for the management of cataract in the Clinic of Ophthalmology, Clinical centre Kragujevac, Kragujevac, Serbia.

Methods:

One hundred and ninty eight eyes of 179 patients undergoing routine cataract surgery. Postoperatively anti-inflammatory medication was either dexamethasone (N = 99) or diclofenac and dexamethason (N = 99). Spectral domain optical coherence tomography imaging was conducted before surgery and at the control visit 28 days postoperatively.

Results:

In patients having pseudoexfoliation syndrome, central retinal thickness increase (mean ± standard error of the mean) was 71.3 ± 22.5 μm for dexamethasone and 12.3 ± 3.9 μm for diclofenac and dexamethason, compared to 22.1 ± 6.4 μm and 7.1 ± 0.9 μm in eyes without pseudoexfoliation syndrome, respectively. Best corrected visual acuity gain and best corrected visual acuity at 28 days were less in patients having pseudoexfoliation syndrome compared to those without (0.41 ± 0.05 vs 0.65 ± 0.04 decimals, P = 0.007; and 0.71 ± 0.04 vs 0.95 ± 0.07 decimals, P = 0.008, respectively).

Conclusions:

Eyes with pseudoexfoliation syndrome may be predisposed to an increased macular edema after cataract surgery. This study suggests that forced anti inflammatory therapy (corticosteroids and NSAID) is imperative for the patients with PEX after cataract surgery.

Financial Disclosure:

None